γ-secretase directly sheds the survival receptor BCMA from plasma cells

Nature Communications

Volumn 6, Issue , 2015, Pages

  Laurent, Sarah A ^a   Hoffmann, Franziska S ^a   Kuhn, Peer Hendrik ^b,c   Cheng, Qingyu ^d   Chu, Yuanyuan ^e   Schmidt Supprian, Marc ^e   Hauck, Stefanie M ^f   Schuh, Elisabeth ^a   Krumbholz, Markus ^a   Rübsamen, Heike ^a   Wanngren, Johanna ^b,c   Khademi, Mohsen ^g   Olsson, Tomas ^g   Alexander, Tobias ^d   Hiepe, Falk ^d   Pfister, Hans Walter ^h   Weber, Frank ⁱ   Jenne, Dieter ^f   Wekerle, Hartmut ^j,k   Hohlfeld, Reinhard ^a,k   Lichtenthaler, Stefan F ^b,c,k   Meinl, Edgar ^a   more..

^a UNIVERSITY OF MUNICH   (Germany)

^b TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^c GERMAN CENTER FOR NEURODEGENERATIVE DISEASES DZNE   (Germany)

^d CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^e TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^f INSTITUTE OF EPIDEMIOLOGY   (Germany)

^g KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^h LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

ⁱ MAX PLANCK INSTITUTE OF PSYCHIATRY   (Germany)

^j MAX PLANCK INSTITUTE OF NEUROBIOLOGY   (Germany)

^k Technische Universität München Munich Cluster for Systems Neurology   (Germany)

more..

Author keywords

[No Author keywords available]

Indexed keywords

APRIL PROTEIN; B CELL MATURATION ANTIGEN; BETA SECRETASE; BIOLOGICAL MARKER; IMMUNOGLOBULIN G; SECRETASE; TNFRSF17 PROTEIN, HUMAN;

ANTIGEN; CYTOLOGY; ENZYME ACTIVITY;

ARTICLE; AUTOIMMUNE DISEASE; B LYMPHOCYTE; BONE MARROW; CELL SURVIVAL; CEREBROSPINAL FLUID; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE ACTIVITY; HUMAN; IMMUNOGLOBULIN PRODUCTION; IN VITRO STUDY; IN VIVO STUDY; INHIBITION KINETICS; MULTIPLE SCLEROSIS; PLASMA CELL; SYSTEMIC LUPUS ERYTHEMATOSUS; ANTAGONISTS AND INHIBITORS; CELL DIFFERENTIATION; CYTOLOGY; HEK293 CELL LINE; METABOLISM;

AMYLOID PRECURSOR PROTEIN SECRETASES; B-CELL MATURATION ANTIGEN; CELL DIFFERENTIATION; HEK293 CELLS; HUMANS; PLASMA CELLS;

EID: 84931291652     PISSN: None     EISSN: 20411723     Source Type: Journal    
DOI: 10.1038/ncomms8333     Document Type: Article

References (54)

1. Dörner, T., Radbruch, A., Burmester, G. R. B-cell-directed therapies for autoimmune disease. Nat. Rev. Rheumatol. 5, 433-441 (2009).
2. Krumbholz, M., Derfuss, T., Hohlfeld, R., Meinl, E. B cells and antibodies in multiple sclerosis pathogenesis and therapy. Nat. Rev. Neurol. 8, 613-623 (2012).
3. Mackay, F., Schneider, P. Cracking the BAFF code. Nat. Rev. Immunol. 9, 491-502 (2009).
4. Yang, M. et al. B cell maturation antigen, the receptor for a proliferationinducing ligand and B cell-activating factor of the TNF family, induces antigen presentation in B cells. J. Immunol. 175, 2814-2824 (2005).
5. Darce, J. R., Arendt, B. K., Wu, X., Jelinek, D. F. Regulated expression of BAFF-binding receptors during human B cell differentiation. J. Immunol. 179, 7276-7286 (2007).
6. Avery, D. T. et al. BAFF selectively enhances the survival of plasmablasts generated from human memory B cells. J. Clin. Invest. 112, 286-297 (2003).
7. O'Connor, B. P. et al. BCMA is essential for the survival of long-lived bone marrow plasma cells. J. Exp. Med. 199, 91-98 (2004).
8. Peperzak, V. et al. Mcl-1 is essential for the survival of plasma cells. Nat. Immunol. 14, 290-297 (2013).
9. Belnoue, E. et al. APRIL is critical for plasmablast survival in the bone marrow and poorly expressed by early-life bone marrow stromal cells. Blood 111, 2755-2764 (2008).
10. Benson, M. J. et al. Cutting edge: the dependence of plasma cells and independence of memory B cells on BAFF and APRIL. J. Immunol. 180, 3655-3659 (2008).
11. Amanna, I. J., Slifka, M. K. Mechanisms that determine plasma cell lifespan and the duration of humoral immunity. Immunol. Rev. 236, 125-138 (2010).
12. Hiepe, F. et al. Long-lived autoreactive plasma cells drive persistent autoimmune inflammation. Nat. Rev. Rheumatol. 7, 170-178 (2011).
13. Croft, M., Benedict, C. A., Ware, C. F. Clinical targeting of the TNF and TNFR superfamilies. Nat. Rev. Drug Discov. 12, 147-168 (2013).
14. Stohl, W., Scholz, J. L., Cancro, M. P. Targeting BLyS in rheumatic disease: the sometimes-bumpy road from bench to bedside. Curr. Opin. Rheumatol. 23, 305-310 (2011).
15. Kappos, L. et al. Atacicept in multiple sclerosis (ATAMS): a randomised, placebo-controlled, double-blind, phase 2 trial. Lancet Neurol. 13, 353-363 (2014).
16. Kopan, R., Ilagan, M. X. Gamma-secretase: proteasome of the membrane? Nat. Rev. Mol. Cell Biol. 5, 499-504 (2004).
17. Selkoe, D. J., Wolfe, M. S. Presenilin: running with scissors in the membrane. Cell 131, 215-221 (2007).
18. Ransohoff, R. M., Engelhardt, B. The anatomical and cellular basis of immune surveillance in the central nervous system. Nat. Rev. Immunol. 12, 623-635 (2012).
19. Pinna, D., Corti, D., Jarrossay, D., Sallusto, F., Lanzavecchia, A. Clonal dissection of the human memory B-cell repertoire following infection and vaccination. Eur. J. Immunol. 39, 1260-1270 (2009).
20. Avery, D. T. et al. Increased expression of CD27 on activated human memory B cells correlates with their commitment to the plasma cell lineage. J. Immunol. 174, 4034-4042 (2005).
21. Herreman, A. et al. Total inactivation of gamma-secretase activity in presenilindeficient embryonic stem cells. Nat. Cell Biol. 2, 461-462 (2000).
22. Yamasaki, A. et al. The GxGD motif of presenilin contributes to catalytic function and substrate identification of gamma-secretase. J. Neurosci. 26, 3821-3828 (2006).
23. Bossen, C., Schneider, P. BAFF, APRIL and their receptors: structure, function and signaling. Semin. Immunol. 18, 263-275 (2006).
24. Luzina, I. G. et al. Spontaneous formation of germinal centers in autoimmune mice. J. Leukoc. Biol. 70, 578-584 (2001).
25. Cassese, G. et al. Inflamed kidneys of NZB/W mice are a major site for the homeostasis of plasma cells. Eur. J. Immunol. 31, 2726-2732 (2001).
26. Yu, G. et al. APRIL and TALL-I and receptors BCMA and TACI: system for regulating humoral immunity. Nat. Immunol. 1, 252-256 (2000).
27. Rennert, P. et al. A soluble form of B cell maturation antigen, a receptor for the tumor necrosis factor family member APRIL, inhibits tumor cell growth. J. Exp. Med. 192, 1677-1684 (2000).
28. Struhl, G., Adachi, A. Requirements for presenilin-dependent cleavage of notch and other transmembrane proteins. Mol. Cell 6, 625-636 (2000).
29. Hemming, M. L., Elias, J. E., Gygi, S. P., Selkoe, D. J. Proteomic profiling of gamma-secretase substrates and mapping of substrate requirements. PLoS Biol. 6, e257 (2008).
30. Day, E. S. et al. Selectivity of BAFF/BLyS and APRIL for binding to the TNF family receptors BAFFR/BR3 and BCMA. Biochemistry (Mosc. ) 44, 1919-1931 (2005).
31. Castigli, E. et al. Impaired IgA class switching in APRIL-deficient mice. Proc. Natl Acad. Sci. USA 101, 3903-3908 (2004).
32. Radtke, F., MacDonald, H. R., Tacchini-Cottier, F. Regulation of innate and adaptive immunity by Notch. Nat. Rev. Immunol. 13, 427-437 (2013).
33. Simonetti, G. et al. IRF4 controls the positioning of mature B cells in the lymphoid microenvironments by regulating NOTCH2 expression and activity. J. Exp. Med. 210, 2887-2902 (2013).
34. Yoon, S. O., Zhang, X., Berner, P., Blom, B., Choi, Y. S. Notch ligands expressed by follicular dendritic cells protect germinal center B cells from apoptosis. J. Immunol. 183, 352-358 (2009).
35. Yagi, T. et al. Defective signal transduction in B lymphocytes lacking presenilin proteins. Proc. Natl Acad. Sci. USA 105, 979-984 (2008).
36. Levine, S. J. Molecular mechanisms of soluble cytokine receptor generation. J. Biol. Chem. 283, 14177-14181 (2008).
37. Xanthoulea, S. et al. Tumor necrosis factor (TNF) receptor shedding controls thresholds of innate immune activation that balance opposing TNF functions in infectious and inflammatory diseases. J. Exp. Med. 200, 367-376 (2004).
38. Hoffmann, F. S. et al. The Immunoregulator Soluble TACI Is Released by ADAM10 and Reflects B Cell Activation in Autoimmunity. J. Immunol. 194, 542-552 (2015).
39. von Budingen, H. C., Bar-Or, A., Zamvil, S. S. B cells in multiple sclerosis: connecting the dots. Curr. Opin. Immunol. 23, 713-720 (2011).
40. Nylander, A., Hafler, D. A. Multiple sclerosis. J. Clin. Invest. 122, 1180-1188 (2012).
41. Krumbholz, M. et al. BAFF is produced by astrocytes and up-regulated in multiple sclerosis lesions and primary central nervous system lymphoma. J. Exp. Med. 201, 195-200 (2005).
42. Cepok, S. et al. Short-lived plasma blasts are the main B cell effector subset during the course of multiple sclerosis. Brain 128, 1667-1676 (2005).
43. Stohl, W. et al. B lymphocyte stimulator overexpression in patients with systemic lupus erythematosus: longitudinal observations. Arthritis Rheum. 48, 3475-3486 (2003).
44. Kim, J., Gross, J. A., Dillon, S. R., Min, J. K., Elkon, K. B. Increased BCMA expression in lupus marks activated B cells, and BCMA receptor engagement enhances the response to TLR9 stimulation. Autoimmunity 44, 69-81 (2011).
45. Vincent, F. B., Saulep-Easton, D., Figgett, W. A., Fairfax, K. A., Mackay, F. The BAFF/APRIL system: emerging functions beyond B cell biology and autoimmunity. Cytokine Growth Factor Rev. 24, 203-215 (2013).
46. Osorio, C. et al. Selective regulation of axonal growth from developing hippocampal neurons by tumor necrosis factor superfamily member APRIL. Mol. Cell Neurosci. 59C, 24-36 (2014).
47. Sanchez, E. et al. Serum B-cell maturation antigen is elevated in multiple myeloma and correlates with disease status and survival. Br. J. Haematol. 158, 727-738 (2012).
48. Minter, L. M. et al. Inhibitors of gamma-secretase block in vivo and in vitro T helper type 1 polarization by preventing Notch upregulation of Tbx21. Nat. Immunol. 6, 680-688 (2005).
49. Burger, R. et al. Interleukin-6 production in B-cell neoplasias and Castleman's disease: evidence for an additional paracrine loop. Ann. Hematol. 69, 25-31 (1994).
50. Hauck, S. M. et al. Deciphering membrane-associated molecular processes in target tissue of autoimmune uveitis by label-free quantitative mass spectrometry. Mol. Cell Proteomics 9, 2292-2305 (2010).
51. Mitterreiter, S. et al. Bepridil and amiodarone simultaneously target the Alzheimer's disease beta-and gamma-secretase via distinct mechanisms. J. Neurosci. 30, 8974-8983 (2010).
52. Perera, N. C. et al. NSP4 is stored in azurophil granules and released by activated neutrophils as active endoprotease with restricted specificity. J. Immunol. 191, 2700-2707 (2013).
53. Pasare, C., Medzhitov, R. Control of B-cell responses by Toll-like receptors. Nature 438, 364-368 (2005).
54. Hoyer, B. F. et al. Short-lived plasmablasts and long-lived plasma cells contribute to chronic humoral autoimmunity in NZB/W mice. J. Exp. Med. 199, 1577-1584 (2004).